Няма интернет връзка — показва се запазената версия на страницата.

10x Genomics, Inc…

USUSD
← Към скрийнъра
US:TXGLSE:0A88

10x Genomics, Inc. (US:TXG) — Biotechnology: Laboratory Analytical Instruments. Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.

За компанията

Уебсайт
10xgenomics.com
Сектор
Industrials · Biotechnology: Laboratory Analytical Instruments
Централа
Pleasanton, United States
Изпълнителен директор
Dr. Serge Saxonov Ph.D.
Служители
1 178
Основана
2012
Акции в обращение
120.21 млн
Свободно търгуеми акции
118.19 млн
Пазарна капитализация
11.53 млрд USD
Инсайдери
1.46%
Институционални инвеститори
120.2%
Отрасъл (SIC)
Laboratory Analytical Instruments
ISIN
US88025U1097
LEI
5493003Z6741WNLG7H43
Коефициент на изплащане
0%
FCF
121 млн USD
Дълг
0 USD
нетни парични средства
Дивидентна история
—
Печалба, FCF и изплатени дивиденти — за 12-те месеца до 30.06.2026 (последният отчет на компанията).
Описание

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Борси и тикери

БорсаТикерВалутаЦенаВид
US USA StocksTXG основенUSD77.28 +1.55%обикновени акции
LSE London Stock Exchange0A88 IOBUSD88.31 +0.00%обикновени акции

Цена за 3 месеца

ден на ръст ден на спад екс-дата на дивидента дата на изплащанеПосочете / докоснете ден — цени на отваряне, затваряне, най-висока и най-ниска

Дивиденти

Не са намерени дивидентни плащания (проверено 09.10.2026). Вероятно компанията не изплаща дивиденти.

Новини тази седмица

Все още няма новини от сайта на компанията.

реклама

Най-големи притежатели

ПритежателДялАкцииДата на доклада
FMR, LLC14.67%17.63 млн2026-06-30
Blackrock Inc.8.99%10.8 млн2026-06-30
ARK Investment Managemen…8.32%10 млн2026-06-30
Vanguard Portfolio Manag…5.81%6.98 млн2026-06-30
Quantinno Capital Manage…4.55%5.47 млн2026-06-30
Vanguard Capital Managem…4.23%5.08 млн2026-06-30
Price (T.Rowe) Associate…3.78%4.54 млн2026-06-30
Sumitomo Mitsui Trust Gr…3.49%4.19 млн2026-06-30
Amova Asset Management A…3.49%4.19 млн2026-06-30
VANGUARD INDEX FUNDS-Van…2.94%3.53 млн2026-06-30
Morgan Stanley2.79%3.35 млн2026-06-30
iShares Trust-iShares Ru…2.53%3.04 млн2026-07-31
ARK ETF Trust-ARK Genomi…2.53%3.04 млн2026-08-31
ARK ETF Trust-ARK Innova…2.5%3.01 млн2026-08-31
VANGUARD INDEX FUNDS-Van…2.12%2.55 млн2026-06-30
Fidelity Select PORT.s-S…1.66%2 млн2026-07-31
Fidelity Rutland Square…1.37%1.65 млн2026-07-31
Fidelity Select Portfoli…1.34%1.61 млн2026-07-31
VANGUARD INDEX FUNDS-Van…1.22%1.47 млн2026-06-30
T. Rowe Price New Horizo…1.21%1.46 млн2026-06-30
SAXONOV SERGE WILSON (Ch…≈1.11%1.34 млн2026-09-22
HINDSON BENJAMIN J (Pres…≈0.41%488 1822026-08-24
STUELPNAGEL JOHN R (Dire…≈0.27%328 4362026-09-03
TAICH ADAM (Chief Financ…≈0.26%316 3442026-09-09
MATEO ALAN V. (Director)≈0.07%85 8772026-06-04
KOSARAJU SRIDHAR (Direct…≈0.06%68 2782026-06-04
POPOVITS KIMBERLY J (Dir…≈0.03%37 4452026-06-04
TEICHMANN SARAH A. (Dire…≈0.02%28 0582026-08-14
SULIMAN SHEHNAAZ (Direct…≈0.02%23 7922026-09-22